Xeris Biopharma Holdings
XERS
XERS
101 hedge funds and large institutions have $89.3M invested in Xeris Biopharma Holdings in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 27 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
1.64% less ownership
Funds ownership: 43.75% → 42.11% (-1.6%)
2% less funds holding
Funds holding: 103 → 101 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Holders
101
Holding in Top 10
2
Calls
$2.13M
Puts
$148K
Top Buyers
| 1 | +$2M | |
| 2 | +$346K | |
| 3 | +$337K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$280K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$244K |
Top Sellers
| 1 | -$5.18M | |
| 2 | -$851K | |
| 3 | -$303K | |
| 4 |
Jane Street
New York
|
-$231K |
| 5 |
Lazard Asset Management
New York
|
-$182K |